dopaminergic receptor

dopaminergic receptor

a protein on the surfaces of certain cells that binds specifically to the neurotransmitter dopamine. Such receptors on vascular epithelial cells, when stimulated by dopamine, cause the renal mesenteric, coronary, and cerebral arteries to dilate and the flow of blood to increase.
References in periodicals archive ?
Ejaculatory disturbances, diminished sexual desire, and erectile dysfunction associated with risperidone have been reported and several mechanisms including central dopaminergic receptor blockade, a-adrenergic antagonism, and prolactin elevation have been proposed (17,18,19,20).
8] Domperidone, a peripheral D2 dopaminergic receptor antagonist, is administered prior to apomorphine for prevention of nausea, vomiting, drowsiness and orthostasis.
If confirmed it will suggest that NAAT "normalizes" brain abnormalities associated with drug dependence (alcohol, heroin and psychostimulants) induced by dopaminergic deficiency by acting as a dopaminergic receptor agonist during protracted abstinence in polydrug abusers.
1] activity antagonists that reverted the effects of d-amphetamine on the quarter life, it could be thought that this subtype of dopaminergic receptor could have a greater implication in the perception of time.
An emerging theory starts linking OTR and VRS to the dopaminergic receptor region as a 'reward center' (109).
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Administration of endosulfan during gestation and lactation in rats up to 2-3 weeks of age produced a significant decrease in the affinity and maximum numbers of striatal dopaminergic receptors without affecting other receptor profiles, suggesting that dopaminergic receptors are unusually sensitive to the action of endosulfan (Seth et al.
5] Droperidol, another effective antiemetic, inhibits dopaminergic receptors in the chemoreceptor trigger zone, although it does not always influence labyrinth-induced vomiting.
One such collaboration is the EUREKA project 781, the iodolisuride ligand for D2 dopaminergic receptors.
It drives our dopaminergic receptors in the prefrontal cortex wild and we love it.
Ergo Science researchers established that stimulation of two dopaminergic receptors produced a significant (between 50 and 60%) reduction in food intake, dramatic weight loss and a decrease in fat stores of 22-32% with no significant decrease in lean body (muscle) mass.
Dopamine is unable to cross into the central nervous system (CNS) and therefore affects only peripheral dopaminergic receptors.